Consolidated services include:

  • Active patient clinic – allowing for immediate access to a pool of potential patient participants 

  • FDA and ISO registered specialty lens manufacturing lab (FDA 21 CFR Part 820 Quality System Regulation and ISO 13485:2016 compliant) 

  • Clinical research coordinator 

  • Clinical researchers 

  • Experienced Principal Investigators 

  • Experienced software engineers in specialty lens and ocular surface disease R&D

  • Data analysts to provide support for writing and publication

  • A fellowship-trained corneal and external disease ophthalmologist

  • Cornea and contact lens residency-trained, board-certified optometrists

With everything under one roof, from clinic to lab to patient recruitment, as well as connections with specialty lens providers across the country and world, BostonSight is an ideal clinical research partner, providing peace of mind, oversight, and a streamlined site to initiate your study.  

We also disseminate research study results through peer-reviewed publications, industry publications, ocular surface disease education, conference proceedings, and other presentations by our clinical staff. 

See our current Research Publications. 

Clinical Trials We Support Include: 

  • Treatment studies – prospective studies that test treatments, such as investigational drugs or scleral lens devices 
  • Behavioral studies – studies that review the impact of ocular surface disease and/or treatments on behavior, such as mental health 
  • Observational studies – retrospective or prospective studies to evaluate the efficacy of scleral lens technology 
  • Diagnostic studies – studies that evaluate new avenues for diagnosing ocular surface diseases and innovative technologies 

Recently Completed Studies:

  • Novel Use of Restasis (Cyclosporine Ophthalmic Emulsion 0.05%) on the Application of PROSE Devices for Management of Patients with Ocular Surface Disåease: A Pilot Study 
  • 12-Week Clinical Study to Evaluate a New Investigational Eye Drop for Patients Who Have Ongoing Eye Pain/Dry Eye Symptoms and Have Had Refractive or Cataract Surgery 
  • A Phase II/III Trial of Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients with Ocular Graft-Versus-Host Disease 
  • An Evaluation of Tangible Boost (Hydra-PEG) at Home Lens Coating System for Patients with Dry Eye Syndrome, Steven Johnson Syndrome, Sjögren’s Syndrome, and Graft Versus Host Disease 
  • Pilot Study to Investigate the Feasibility, Reliability, and Efficiency of Utilizing Ocular Surface Optical Coherence Tomography to Automate PROSE Fitting 
  • Measuring Eye Pressure in Patients Wearing Scleral Lenses 

Partner with Us 

To inquire about partnering with BostonSight Center for Ocular Surface Health, please contact Dr. Daniel Brocks, Chief Medical Officer, via Estelle Crowley, Clinical Research Coordinator, at ecrowley@bostonsight.org.